Belite Bio (BLTE) is down -9.3%, or -$12.65 to $123.35.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Belite Bio rises 16.3%
- Belite Bio assumed with an Overweight at Cantor Fitzgerald
- Astera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
- Belite Bio initiated with a Neutral at Mizuho
- Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support